Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zehan Chen

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Bioorganic & Medicinal Chemistry|February 9, 2007
Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitorsYunsong Tong, Akiyo Claiborne, Kent D Stewart, et al.
International Journal of Cancer|October 5, 2006
Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeuticsZehan Chen, Zhan Xiao, Wen-Zhen Gu, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2007
Cyanopyridyl containing 1,4-dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: improving oral biovailabilityYunsong Tong, Magdalena Przytulinska, Zhi-Fu Tao, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 6, 2024
Design Principles of Quinone Redox Systems for Advanced Sulfide Solid-State Organic Lithium Metal BatteriesXiaodong Lin, Petru Apostol, Hewei Xu, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2007
1,4-Dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: extended exploration on phenyl ring substitutions and preliminary ADME/PK studiesYunsong Tong, Akiyo Claiborne, Magdalena Pyzytulinska, et al.
Journal of Medicinal Chemistry|July 31, 2007
Design, synthesis, and biological activity of 5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-one-based potent and selective Chk-1 inhibitorsLe Wang, Gerard M Sullivan, Laura A Hexamer, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 2012
Preclinical characterization of ABT-348, a kinase inhibitor targeting the aurora, vascular endothelial growth factor receptor/platelet-derived growth factor receptor, and Src kinase familiesKeith B Glaser, Junling Li, Patrick A Marcotte, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Bioorganic & Medicinal Chemistry|February 9, 2007
Discovery of 1,4-dihydroindeno[1,2-c]pyrazoles as a novel class of potent and selective checkpoint kinase 1 inhibitorsYunsong Tong, Akiyo Claiborne, Kent D Stewart, et al.
International Journal of Cancer|October 5, 2006
Selective Chk1 inhibitors differentially sensitize p53-deficient cancer cells to cancer therapeuticsZehan Chen, Zhan Xiao, Wen-Zhen Gu, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2007
Cyanopyridyl containing 1,4-dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: improving oral biovailabilityYunsong Tong, Magdalena Przytulinska, Zhi-Fu Tao, et al.
Advanced Materials (Deerfield Beach, Fla.)|June 6, 2024
Design Principles of Quinone Redox Systems for Advanced Sulfide Solid-State Organic Lithium Metal BatteriesXiaodong Lin, Petru Apostol, Hewei Xu, et al.
Bioorganic & Medicinal Chemistry Letters|May 11, 2007
1,4-Dihydroindeno[1,2-c]pyrazoles as potent checkpoint kinase 1 inhibitors: extended exploration on phenyl ring substitutions and preliminary ADME/PK studiesYunsong Tong, Akiyo Claiborne, Magdalena Pyzytulinska, et al.
Journal of Medicinal Chemistry|July 31, 2007
Design, synthesis, and biological activity of 5,10-dihydro-dibenzo[b,e][1,4]diazepin-11-one-based potent and selective Chk-1 inhibitorsLe Wang, Gerard M Sullivan, Laura A Hexamer, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 1, 2012
Preclinical characterization of ABT-348, a kinase inhibitor targeting the aurora, vascular endothelial growth factor receptor/platelet-derived growth factor receptor, and Src kinase familiesKeith B Glaser, Junling Li, Patrick A Marcotte, et al.
Pageof 4